Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
05 2022
Historique:
entrez: 20 5 2022
pubmed: 21 5 2022
medline: 25 5 2022
Statut: ppublish

Résumé

An expert panel on breast cancer and COVID-19 disease was convened to address the impact of the COVID-19 pandemic for early breast cancer (eBC) management. To ensure that the most clinically relevant information was addressed, essential information was drawn from several of the latest national and international guidelines and another technical document. The expert panel met in five virtual closed sessions from November 2020 to May 2021 to consult on the relevant data from evidence-based results. The data gathered were discussed on an online platform. This article reports the expert panel's highlights of these meetings' discussions. In addition, it provides practical recommendations covering topics regarding diagnosis, treatment, and management of patients with eBC in clinical settings routinely encountered by health care professionals amid the COVID-19 pandemic. This article provided guidance on several topics regarding eBC management amid the COVID-19 pandemics to inform safer care practices.

Identifiants

pubmed: 35594492
doi: 10.1200/GO.21.00357
pmc: PMC9173577
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2100357

Références

JAMA. 2017 Sep 12;318(10):918-926
pubmed: 28898379
Lancet Oncol. 2015 Mar;16(3):266-73
pubmed: 25637340
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
JAMA Netw Open. 2020 Aug 3;3(8):e2017267
pubmed: 32749465
Can Assoc Radiol J. 2021 Nov;72(4):601-602
pubmed: 33622040
Radiology. 2021 Jul;300(1):E296-E300
pubmed: 33625300
JAMA. 2013 Oct 9;310(14):1455-61
pubmed: 24101169
Surgery. 2020 Jul;168(1):4-10
pubmed: 32451162
J Surg Oncol. 2020 Dec;122(7):1293-1295
pubmed: 32786076
Breast Cancer. 2019 May;26(3):373-377
pubmed: 30666563
Adv Immunol. 2014;122:91-128
pubmed: 24507156
CA Cancer J Clin. 2017 Sep;67(5):398-410
pubmed: 28753241
Ann Surg Oncol. 2020 Feb;27(2):344-351
pubmed: 31823173
Can J Surg. 2020 May 1;63(22):S2-S4
pubmed: 32343118
Ann Surg Oncol. 2020 Aug;27(8):2600-2613
pubmed: 32535870
JAMA Oncol. 2021 Oct 1;7(10):1507-1513
pubmed: 34236381
JAMA Oncol. 2021 Sep 1;7(9):1395-1397
pubmed: 34292295
Ann Oncol. 2015 Aug;26(8):1533-46
pubmed: 25939896
Nat Med. 2020 Apr;26(4):453-455
pubmed: 32284614
J Clin Oncol. 2016 Apr 1;34(10):1072-8
pubmed: 26811528
Ann Intern Med. 2020 Sep 15;173(6):450-460
pubmed: 32496919
Anaesthesia. 2018 Jan;73 Suppl 1:25-33
pubmed: 29313906
Lung Cancer. 2010 May;68(2):234-9
pubmed: 19665818
Eur J Cancer. 2021 May;148:316-327
pubmed: 33770576
Ann Surg Oncol. 2021 Feb;28(2):930-940
pubmed: 32712895
J Med Virol. 2020 Jul;92(7):903-908
pubmed: 32219885
In Vivo. 2020 Jun;34(3 Suppl):1667-1673
pubmed: 32503827
JAMA Surg. 2018 Dec 1;153(12):1120-1126
pubmed: 30193375
Breast Cancer Res Treat. 2020 Jun;181(3):487-497
pubmed: 32333293
MMWR Morb Mortal Wkly Rep. 2021 Jan 01;69(5152):1642-1647
pubmed: 33382679
Br J Surg. 2018 Nov;105(12):1541-1552
pubmed: 30311642
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Breast Cancer Res Treat. 2018 Jul;170(2):373-379
pubmed: 29546481
Breast Cancer Res Treat. 2020 Nov;184(1):249-254
pubmed: 32772225
Breast Cancer Res Treat. 2021 Aug;188(3):825-826
pubmed: 34156582
Breast Cancer Res Treat. 2020 Nov;184(2):637-647
pubmed: 32803637
Support Care Cancer. 2001 Jan;9(1):65-8
pubmed: 11147146
Ann Surg Oncol. 2021 Mar;28(3):1358-1367
pubmed: 32869154
Cochrane Database Syst Rev. 2020 Aug 26;8:CD013705
pubmed: 32845525
Nat Rev Clin Oncol. 2021 May;18(5):313-319
pubmed: 33723371
Int J Infect Dis. 2021 Feb;103:260-267
pubmed: 33232832
Breast. 2019 Apr;44:113-119
pubmed: 30738289
PLoS One. 2011;6(11):e27214
pubmed: 22087267
Lancet Oncol. 2021 Jun;22(6):765-778
pubmed: 33930323
N Engl J Med. 2019 Feb 14;380(7):617-628
pubmed: 30516102
AJR Am J Roentgenol. 2021 Oct;217(4):831-834
pubmed: 33543649
Oncoimmunology. 2021 Jan 4;10(1):1854424
pubmed: 33489469
Breast. 2020 Aug;52:8-16
pubmed: 32334323
Lancet Oncol. 2013 Oct;14(11):1086-1094
pubmed: 24055415
Ann Surg Oncol. 2021 Oct;28(11):6044-6050
pubmed: 33876362
Br J Cancer. 2011 May 24;104(11):1670-4
pubmed: 21540859
J Plast Reconstr Aesthet Surg. 2021 Mar;74(3):644-710
pubmed: 33012691
Cochrane Database Syst Rev. 2018 Feb 01;2:CD008983
pubmed: 29388675
Breast J. 2017 Sep;23(5):554-562
pubmed: 28295828
JAMA. 2020 Jun 9;323(22):2249-2251
pubmed: 32374370
Br J Surg. 2018 Dec;105(13):1778-1792
pubmed: 30132807
Anaesthesia. 2021 Jun;76(6):748-758
pubmed: 33690889
Ann Oncol. 2019 Aug 1;30(8):1194-1220
pubmed: 31161190
Nat Cancer. 2021 Apr;2(4):392-399
pubmed: 34661163
Ann Surg Oncol. 2020 Jun;27(6):1717-1720
pubmed: 32270420
N Engl J Med. 2017 Jun 1;376(22):2147-2159
pubmed: 28564564
Radiother Oncol. 2016 Jul;120(1):114-8
pubmed: 27046390
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Bone Joint J. 2020 Sep;102-B(9):1136-1145
pubmed: 32634023
J Clin Oncol. 2010 Jun 1;28(16):2784-95
pubmed: 20404251
N Engl J Med. 2021 Jun 24;384(25):2394-2405
pubmed: 34081848
Ann Surg Oncol. 2021 Mar;28(3):1289-1297
pubmed: 32980998
Ann Surg Oncol. 2018 Jun;25(6):1488-1494
pubmed: 29572705
Ann Surg Oncol. 2015 Oct;22(11):3407-8
pubmed: 25994211
JCO Oncol Pract. 2020 Oct;16(10):665-674
pubmed: 32603252
ACS Sens. 2020 Dec 24;5(12):3655-3677
pubmed: 33267587
ESMO Open. 2020 May;5(Suppl 3):
pubmed: 32439716
Int Immunopharmacol. 2021 Jan;90:107247
pubmed: 33307513

Auteurs

Francisco Pimentel Cavalcante (FP)

Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil.

Edson Abdala (E)

Department of Infectious and Parasitic Diseases, School of Medicine, University of São Paulo (USP), São Paulo, SP, Brazil.

Leonardo Weissmann (L)

Emílio Ribas Infectious Disease Institute, São Paulo, SP, Brazil.
Unaerp School of Medicine, Guarujá, SP, Brazil.
Brazilian Society of Infectology, São Paulo, SP, Brazil.

Carlos Eduardo Dos Santos Ferreira (CEDS)

Albert Einstein Hospital, São Paulo, SP, Brazil.
Brazilian Society of Clinical Pathology/Laboratory Medicine, Rio de Janeiro, RJ, Brazil.

Gilberto Amorim (G)

Oncologia D'Or, Rio de Janeiro, RJ, Brazil.
Brazilian Breast Cancer Study Group (GBECAM), Porto Alegre, RS, Brazil.

Vilmar Marques de Oliveira (VM)

Brazilian Society of Mastology, Rio de Janeiro, RJ, Brazil.
Santa Casa de São Paulo Hospital, São Paulo, SP, Brazil.
Santa Casa de São Paulo School of Medical Sciences, São Paulo, SP, Brazil.

Gisah Guilgen (G)

Brazilian Breast Cancer Study Group (GBECAM), Porto Alegre, RS, Brazil.
Curitiba Cancer and Transplant Institute, Curitiba, PR, Brazil.
Nossa Senhora das Graças Hospital, Curitiba, PR, Brazil.

Luciana Landeiro (L)

Núcleo de Oncologia da Bahia (NOB)-Oncoclínicas Group, Salvador, BA, Brazil.

João Renato Rebello Pinho (JRR)

Albert Einstein Hospital, São Paulo, SP, Brazil.
Hospital das Clínicas, São Paulo, SP, Brazil.
School of Medicine, Medical Research Laboratories LIM 03/07, University of São Paulo, São Paulo, SP, Brazil.

Álvaro Pulchinelli (Á)

Brazilian Society of Clinical Pathology/Laboratory Medicine, Rio de Janeiro, RJ, Brazil.
Fleury Group, São Paulo, SP, Brazil.
School of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil.

Heber Ribeiro (H)

Brazilian Society of Oncology Surgery, Rio de Janeiro, RJ, Brazil.
AC Camargo Cancer Center, São Paulo, SP, Brazil.

Rafael Souza (R)

Cancer Treatment Institute (ITC), Campo Grande, MS, Brazil.

Daniela Dornelles Rosa (DD)

Brazilian Breast Cancer Study Group (GBECAM), Porto Alegre, RS, Brazil.
Moinhos de Vento Hospital, Porto Alegre, RS, Brazil.
Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH